Mostrando ítems 11-18 de 18
Clinical experience with integrase inhibitors in HIV-2-infected individuals in Spain
(Journal of Antimicrobial Chemotherapy, 2019-05)
Background: HIV-2 is a neglected virus despite estimates of 1-2 million people being infected worldwide. The virus is naturally resistant to some antiretrovirals used to treat HIV-1 and therapeutic options are limited for ...
The Source of New HIV Infections are People not being Treated or Unaware of their Status
(AIDS Reviews, 2019-04)
The advent of antiretroviral therapy has represented a major breakthrough in infectious diseases. The use of HAART prevents HIV disease progression and restores immunity in HIV carriers. In addition, further transmissions ...
HTLV-1 Infection is Rising Up in Spain Whereas HTLV-2 is Vanishing
(AIDS Reviews, 2019-10)
Infection with human retroviruses is responsible for global epidemics and significant morbidity and mortality worldwide. The current global estimates of infected people are 38 million for HIV-1, 1-2 million for HIV-2, 10 ...
Why Not an Opioid Epidemic in Europe Like in the USA?
(AIDS Reviews, 2019-12)
The CDC reported 70,237 drug overdose deaths in the United States in 2017 (Scholl et al., MMWR 2018; 67: 1419-27). Sadly, this yearly rate has been increasing significantly during the past two decades. Opioids, mostly ...
Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
Background: Whereas HIV-1 has spread globally, HIV-2 is mainly found in West Africa where dual HIV-1/HIV-2 coinfection is nowadays uncommon. Herein, we report the rate, main characteristics, and treatment outcomes of all ...
Occult hepatitis B and HIV infection
(European Journal of Gastroenterology & Hepatology, 2019-11)
Introduction Occult hepatitis B virus (HBV) infection, so-called occult B infection (OBI), is defined by the recognition of HBV-DNA in the absence of serum hepatitis B surface antigen (HBsAg). The HBV-DNA genome in OBI is ...
Hepatitis Delta Estimates in the United States Revisited
(Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019-10-30)
To the Editor—We read with interest the article by Patel and colleagues , which reported an unexpected 33% prevalence of anti–hepatitis delta virus antibodies (anti-HDV-Abs) in a large and representative US household ...
HTLV testing of solid organ transplant donors
(Clinical Transplantation, 2019)
Carta al editor